{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:09:55Z","timestamp":1778918995369,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University-Enterprise Joint Technology Development Project","award":["6010125018"],"award-info":[{"award-number":["6010125018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05535-9","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:59:15Z","timestamp":1775901555000},"page":"2209-2220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GMFB promotes lung adenocarcinoma progression by activating the MAPK\/ERK signaling pathway"],"prefix":"10.1007","volume":"481","author":[{"given":"Luyuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiacheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libo","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"1","key":"5535_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12\u201349","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5535_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"7689","key":"5535_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C (2018) The biology and management of non-small cell lung cancer. Nature 553(7689):446\u2013454","journal-title":"Nature"},{"key":"5535_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.semcancer.2023.01.006","volume":"89","author":"S Huang","year":"2023","unstructured":"Huang S, Yang J, Shen N, Xu Q, Zhao Q (2023) Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective. Semin Cancer Biol 89:30\u201337","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"5535_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1056\/NEJMra1703413","volume":"377","author":"M Reck","year":"2017","unstructured":"Reck M, Rabe KF (2017) Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer. N Engl J Med 377(9):849\u2013861","journal-title":"N Engl J Med"},{"key":"5535_CR6","doi-asserted-by":"publisher","first-page":"102237","DOI":"10.1016\/j.ctrv.2021.102237","volume":"99","author":"L Succony","year":"2021","unstructured":"Succony L, Rassl DM, Barker AP, McCaughan FM, Rintoul RC (2021) Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies. Cancer Treat Rev 99:102237","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"5535_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41419-017-0063-y","volume":"9","author":"TV Denisenko","year":"2018","unstructured":"Denisenko TV, Budkevich IN, Zhivotovsky B (2018) Cell death-based treatment of lung adenocarcinoma. Cell Death Dis 9(2):117","journal-title":"Cell Death Dis"},{"issue":"5","key":"5535_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.annonc.2020.01.065","volume":"31","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld AJ, Rizvi H, Bandlamudi C, Sauter JL, Travis WD, Rekhtman N et al (2020) Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas. Ann Oncol 31(5):599\u2013608","journal-title":"Ann Oncol"},{"issue":"3","key":"5535_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jtho.2023.10.016","volume":"19","author":"N Kubo","year":"2024","unstructured":"Kubo N, Suefuji H, Nakajima M, Tokumaru S, Okano N, Yoshida D et al (2024) Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG). J Thorac Oncol 19(3):491\u2013499","journal-title":"J Thorac Oncol"},{"issue":"Pt 2","key":"5535_CR10","doi-asserted-by":"publisher","first-page":"131678","DOI":"10.1016\/j.ijbiomac.2024.131678","volume":"268","author":"W Sun","year":"2024","unstructured":"Sun W, Wang J, Liu C, Gao F, Ou Q, Tian H et al (2024) SUMOylation of GMFB regulates its stability and function in retinal pigment epithelial cells under hyperglycemia. Int J Biol Macromol 268(Pt 2):131678","journal-title":"Int J Biol Macromol"},{"key":"5535_CR11","doi-asserted-by":"publisher","first-page":"102292","DOI":"10.1016\/j.redox.2022.102292","volume":"52","author":"C Liu","year":"2022","unstructured":"Liu C, Sun W, Zhu T, Shi S, Zhang J, Wang J et al (2022) Glia maturation factor-\u03b2 induces ferroptosis by impairing chaperone-mediated autophagic degradation of ACSL4 in early diabetic retinopathy. Redox Biol 52:102292","journal-title":"Redox Biol"},{"issue":"11","key":"5535_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41419-024-07234-z","volume":"15","author":"J Xu","year":"2024","unstructured":"Xu J, Huang Z, Shi S, Xia J, Chen G, Zhou K et al (2024) Glial maturation factor-\u03b2 deficiency prevents oestrogen deficiency-induced bone loss by remodelling the actin network to suppress adipogenesis of bone marrow mesenchymal stem cells. Cell Death Dis 15(11):829","journal-title":"Cell Death Dis"},{"issue":"5","key":"5535_CR13","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s12276-023-00980-8","volume":"55","author":"S Shi","year":"2023","unstructured":"Shi S, Gu H, Xu J, Sun W, Liu C, Zhu T et al (2023) Glia maturation factor beta deficiency protects against diabetic osteoporosis by suppressing osteoclast hyperactivity. Exp Mol Med 55(5):898\u2013909","journal-title":"Exp Mol Med"},{"issue":"Pt 1","key":"5535_CR14","doi-asserted-by":"publisher","first-page":"145082","DOI":"10.1016\/j.ijbiomac.2025.145082","volume":"318","author":"C Liu","year":"2025","unstructured":"Liu C, Gao F, Zhu L, Sun W, Zhu T, Shi S et al (2025) Extracellular GMFB activates the non-canonical FAS-FAF1 pathway to induce lysosomal dysfunction in early diabetic retinopathy. Int J Biol Macromol 318(Pt 1):145082","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"5535_CR15","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/glia.24486","volume":"72","author":"T Zhu","year":"2024","unstructured":"Zhu T, Li Y, Zhu L, Xu J, Feng Z, Chen H et al (2024) GMFB\/AKT\/TGF-\u03b23 in M\u00fcller cells mediated early retinal degeneration in a streptozotocin-induced rat diabetes model. Glia 72(3):504\u2013528","journal-title":"Glia"},{"issue":"5","key":"5535_CR16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jcmgh.2022.07.016","volume":"14","author":"G Yin","year":"2022","unstructured":"Yin G, Zeng W, Li R, Zeng M, Chen R, Liu Y et al (2022) Glia Maturation Factor-\u03b2 Supports Liver Regeneration by Remodeling Actin Network to Enhance STAT3 Proliferative Signals. Cell Mol Gastroenterol Hepatol 14(5):1123\u20131145","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"5535_CR17","doi-asserted-by":"publisher","first-page":"744331","DOI":"10.3389\/fonc.2021.744331","volume":"11","author":"W Sun","year":"2021","unstructured":"Sun W, Hu C, Wang T, Wang J, Zhang J, Gao F et al (2021) Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Front Oncol 11:744331","journal-title":"Front Oncol"},{"issue":"11","key":"5535_CR18","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.ejca.2010.04.015","volume":"46","author":"YL Li","year":"2010","unstructured":"Li YL, Ye F, Cheng XD, Hu Y, Zhou CY, L\u00fc WG, Xie X (2010) Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer. Eur J Cancer 46(11):2104\u20132118","journal-title":"Eur J Cancer"},{"issue":"5","key":"5535_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","volume":"6","author":"JY Fang","year":"2005","unstructured":"Fang JY, Richardson BC (2005) The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6(5):322\u2013327","journal-title":"Lancet Oncol"},{"key":"5535_CR20","doi-asserted-by":"crossref","unstructured":"Park JI (2023) MAPK-ERK Pathway. Int J Mol Sci;24(11)","DOI":"10.3390\/ijms24119666"},{"key":"5535_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","volume":"85","author":"R Ullah","year":"2022","unstructured":"Ullah R, Yin Q, Snell AH, Wan L (2022) RAF-MEK-ERK pathway in cancer evolution and treatment. Semin Cancer Biol 85:123\u2013154","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"5535_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gendis.2022.05.006","volume":"10","author":"Y Song","year":"2023","unstructured":"Song Y, Bi Z, Liu Y, Qin F, Wei Y, Wei X (2023) Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials. Genes Dis 10(1):76\u201388","journal-title":"Genes Dis"},{"issue":"1","key":"5535_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s43556-022-00110-2","volume":"3","author":"Q Li","year":"2022","unstructured":"Li Q, Li Z, Luo T, Shi H (2022) Targeting the PI3K\/AKT\/mTOR and RAF\/MEK\/ERK pathways for cancer therapy. Mol Biomed 3(1):47","journal-title":"Mol Biomed"},{"issue":"2","key":"5535_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","volume":"66","author":"R Roskoski Jr","year":"2012","unstructured":"Roskoski R Jr. (2012) ERK1\/2 MAP kinases: structure, function, and regulation. Pharmacol Res 66(2):105\u2013143","journal-title":"Pharmacol Res"},{"issue":"1","key":"5535_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1556-0864(15)31506-9","volume":"1","author":"JR Molina","year":"2006","unstructured":"Molina JR, Adjei AA (2006) The Ras\/Raf\/MAPK pathway. J Thorac Oncol 1(1):7\u20139","journal-title":"J Thorac Oncol"},{"issue":"1","key":"5535_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-biochem-052521-040754","volume":"93","author":"H Jeon","year":"2024","unstructured":"Jeon H, Tkacik E, Eck MJ (2024) Signaling from RAS to RAF: The Molecules and Their Mechanisms. Annu Rev Biochem 93(1):289\u2013316","journal-title":"Annu Rev Biochem"},{"issue":"23","key":"5535_CR27","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1158\/0008-5472.CAN-14-2073","volume":"74","author":"EM Goetz","year":"2014","unstructured":"Goetz EM, Ghandi M, Treacy DJ, Wagle N, Garraway LA (2014) ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors. Cancer Res 74(23):7079\u20137089","journal-title":"Cancer Res"},{"issue":"1","key":"5535_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR (2023) Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther 8(1):455","journal-title":"Signal Transduct Target Ther"},{"issue":"22","key":"5535_CR29","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","volume":"26","author":"PJ Roberts","year":"2007","unstructured":"Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26(22):3291\u20133310","journal-title":"Oncogene"},{"key":"5535_CR30","doi-asserted-by":"publisher","first-page":"119499","DOI":"10.1016\/j.lfs.2021.119499","volume":"278","author":"ER Asl","year":"2021","unstructured":"Asl ER, Amini M, Najafi S, Mansoori B, Mokhtarzadeh A, Mohammadi A et al (2021) Interplay between MAPK\/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression. Life Sci 278:119499","journal-title":"Life Sci"},{"issue":"1","key":"5535_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41392-023-01329-3","volume":"8","author":"P Wang","year":"2023","unstructured":"Wang P, Jia X, Lu B, Huang H, Liu J, Liu X et al (2023) Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1\/2. Signal Transduct Target Ther 8(1):96","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"5535_CR32","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.7150\/thno.79493","volume":"13","author":"K Rubio","year":"2023","unstructured":"Rubio K, Romero-Olmedo AJ, Sarvari P, Swaminathan G, Ranvir VP, Rogel-Ayala DG et al (2023) Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer. Theranostics 13(8):2384\u20132407","journal-title":"Theranostics"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05535-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05535-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05535-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:28:44Z","timestamp":1778916524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05535-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["5535"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05535-9","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Qilu Hospital of Shandong University provided the ethics for Human experimental (KYLL-2021-1053) and experimental animals (DWLL-2024-029).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Qilu Hospital of Shandong University provided the ethics for Human experimental (KYLL-2021-1053) and experimental animals (DWLL-2024-029).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}